New Orleans, Louisiana 70112


Purpose:

The purpose of the study is to assess the experiences of individuals with acromegaly who are receiving injections as part of their treatment regimen. Another objective of the study is to compare the patients' perception with their doctors' perceptions. The answers are important to help researchers and physicians understand what it is really like to take currently available treatments so that they can make efforts to improve patients' healthcare experiences, reduce treatment burden and, ultimately, improve patient's quality of life.


Criteria:

Inclusion Criteria: - Age >=18 years-old and <95 years-old - Patient self-reported acromegaly diagnosis which will be further confirmed by a knowledge screening based on current medications and doses - Currently on injectable Somatostatin analogues (SSA), Sandostatin® LAR or Somatuline® Depot, for >=12 months - Have not had a change in dosage of their acromegaly treatment at the time of or since their last office visit - Have seen their treating acromegaly physician within the past 12 +/-2 months NOTE: This timeframe allows two additional months for scheduling an appointment with their physician, since most patients should see their acromegaly physician at least once every 12 months - Ability to read and understand English - Live and receive acromegaly treatments in the US - Willing to provide signed informed consent Exclusion Criteria: - Previous or current participant in Mycapssa® (octreotide capsules) trial - Use of Pegvisomant (Somavert®) monotherapy - Use of Pasireotide (Signifor®)


NCT ID:

NCT03613623


Primary Contact:

Principal Investigator
Lizheng Shi, PhD, MsPharm
Tulane University

Shuqian Liu, MD
Phone: 504-988-1939
Email: sliu9@tulane.edu


Backup Contact:

N/A


Location Contact:

New Orleans, Louisiana 70112
United States

Shuqian Liu, PhD
Phone: 504-988-1939
Email: sliu9@tulane.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.